Proprietary AI analyst is now available
- Public Comps
- Profarma
Profarma Valuation Multiples
Discover revenue and EBITDA valuation multiples for Profarma and similar public comparables like Fangzhou, Green Cross Health, MARX Biotech, d1000 and more.
Profarma Overview
About Profarma
Profarma Distribuidora De Produtos Farmaceuticos SA is a Brazil-based company. It is engaged in wholesale and distribution of pharmaceuticals, cosmetics and similar products, and toiletries. Profarma also holds interests in other companies, regardless of their business sector. The company through its logistics department distributes products in the South, Southeast, Northeast and Center-West regions of Brazil. The firm operates in the pharmaceutical distribution, hospital and specialty, retail segments.
Founded
1961
HQ

Employees
6.3K
Website
Sectors
Financials (FY)
EV
$415M
Valuation Multiples
Start free trialProfarma Financials
Profarma reported last fiscal year revenue of $2B and EBITDA of $102M.
In the same fiscal year, Profarma generated $345M in gross profit, $102M in EBITDA, and $23M in net income.
Profarma P&L
In the most recent fiscal year, Profarma reported revenue of $2B and EBITDA of $102M.
Profarma is profitable as of last fiscal year, with gross margin of 15%, EBITDA margin of 5%, and net margin of 1%.
Financial data powered by Morningstar, Inc.
Profarma Stock Performance
Profarma has current market cap of $162M, and enterprise value of $415M.
Market Cap Evolution
Profarma's stock price is $1.32.
Profarma share price decreased by 5.7% in the last 30 days, and by 23.2% in the last year.
Profarma has an EPS (earnings per share) of $0.19.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $415M | $162M | -5.2% | -5.7% | -20.2% | -23.2% | $0.19 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialProfarma Valuation Multiples
Profarma trades at 0.2x EV/Revenue multiple, and 4.1x EV/EBITDA.
Profarma Financial Valuation Multiples
As of June 5, 2026, Profarma has market cap of $162M and EV of $415M.
Profarma has a P/E ratio of 6.9x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Profarma Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Profarma Margins & Growth Rates
In the most recent fiscal year, Profarma reported gross margin of 15%, EBITDA margin of 5%, and net margin of 1%.
Profarma Margins
Profarma Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Profarma Operational KPIs
Profarma's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.0M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Profarma Competitors
Profarma competitors include Fangzhou, Green Cross Health, MARX Biotech, d1000, BlueMTec, Talea Group, PetMeds, YSB, SC Ropharma and Farmacosmo.
Most Profarma public comparables operate across Pharmacies.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 0.2x | 0.2x | 25.2x | 19.8x | |||
| 0.8x | - | 7.9x | - | |||
| 5.0x | - | 34.7x | - | |||
| 0.3x | - | 4.1x | - | |||
| 0.5x | - | 79.2x | - | |||
| 0.6x | - | 24.4x | - | |||
| 0.1x | 0.1x | (0.8x) | (0.5x) | |||
| 0.0x | - | 2.0x | - | |||
This data is available for Pro users. Sign up to see all Profarma competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Profarma
| When was Profarma founded? | Profarma was founded in 1961. |
| Where is Profarma headquartered? | Profarma is headquartered in Brazil. |
| How many employees does Profarma have? | As of today, Profarma has over 6K employees. |
| Is Profarma publicly listed? | Yes, Profarma is a public company listed on B3. |
| What is the stock symbol of Profarma? | Profarma trades under PFRM3 ticker. |
| When did Profarma go public? | Profarma went public in 2006. |
| Who are competitors of Profarma? | Profarma main competitors include Fangzhou, Green Cross Health, MARX Biotech, d1000, BlueMTec, Talea Group, PetMeds, YSB, SC Ropharma, Farmacosmo. |
| What is the current market cap of Profarma? | Profarma's current market cap is $162M. |
| What is the current revenue of Profarma? | Profarma's last fiscal year revenue is $2B. |
| What is the current EV/Revenue multiple of Profarma? | Current revenue multiple of Profarma is 0.2x. |
| Is Profarma profitable? | No, Profarma is not profitable. |
| How many companies Profarma has acquired to date? | Profarma hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Profarma has invested to date? | Profarma hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Profarma
Lists including Profarma
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.